These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28536426)

  • 1. Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.
    Zhang G; Liu Z; Ding H; Miao H; Garcia JM; Li YP
    Sci Rep; 2017 May; 7(1):2273. PubMed ID: 28536426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
    Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
    Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting.
    Zhang G; Jin B; Li YP
    EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways.
    Doyle A; Zhang G; Abdel Fattah EA; Eissa NT; Li YP
    FASEB J; 2011 Jan; 25(1):99-110. PubMed ID: 20826541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia.
    Bohnert KR; Goli P; Roy A; Sharma AK; Xiong G; Gallot YS; Kumar A
    Mol Cell Biol; 2019 Aug; 39(15):. PubMed ID: 31138662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p300 Mediates Muscle Wasting in Lewis Lung Carcinoma.
    Sin TK; Zhu JZ; Zhang G; Li YP
    Cancer Res; 2019 Apr; 79(7):1331-1342. PubMed ID: 30705122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2.
    Zhang G; Lin RK; Kwon YT; Li YP
    FASEB J; 2013 Jul; 27(7):2893-901. PubMed ID: 23568773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4 mediates the development of fatigue in the murine Lewis Lung Carcinoma model independently of activation of macrophages and microglia.
    Vichaya EG; Ford BG; Quave CB; Rishi MR; Grossberg AJ; Dantzer R
    Psychoneuroendocrinology; 2020 Dec; 122():104874. PubMed ID: 32979744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
    Puppa MJ; Gao S; Narsale AA; Carson JA
    FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes.
    Gao S; Carson JA
    Am J Physiol Cell Physiol; 2016 Jan; 310(1):C66-79. PubMed ID: 26491045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-Like Receptor-4 Disruption Suppresses Adipose Tissue Remodeling and Increases Survival in Cancer Cachexia Syndrome.
    Henriques F; Lopes MA; Franco FO; Knobl P; Santos KB; Bueno LL; Correa VA; Bedard AH; Guilherme A; Birbrair A; Peres SB; Farmer SR; Batista ML
    Sci Rep; 2018 Dec; 8(1):18024. PubMed ID: 30575787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90.
    Zhang G; Liu Z; Ding H; Zhou Y; Doan HA; Sin KWT; Zhu ZJ; Flores R; Wen Y; Gong X; Liu Q; Li YP
    Nat Commun; 2017 Sep; 8(1):589. PubMed ID: 28928431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling.
    Zhu Z; Li C; Gu X; Wang X; Zhang G; Fan M; Zhao Y; Liu X; Zhang X
    Toxicol Appl Pharmacol; 2024 Mar; 484():116846. PubMed ID: 38331105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90.
    Wu HY; Trevino JG; Fang BL; Riner AN; Vudatha V; Zhang GH; Li YP
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morin suppresses cachexia-induced muscle wasting by binding to ribosomal protein S10 in carcinoma cells.
    Yoshimura T; Saitoh K; Sun L; Wang Y; Taniyama S; Yamaguchi K; Uchida T; Ohkubo T; Higashitani A; Nikawa T; Tachibana K; Hirasaka K
    Biochem Biophys Res Commun; 2018 Dec; 506(4):773-779. PubMed ID: 30389140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes.
    Guigni BA; van der Velden J; Kinsey CM; Carson JA; Toth MJ
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E22-E32. PubMed ID: 31689144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
    Kim Y; Oh Y; Kim YS; Shin JH; Lee YS; Kim Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.